top of page
MMG eg FINAL.jpeg
covid 19 shape grey bg.png

Know yourself.

Manage Your Health Better with Genomepatri™ - The Next-Generation Health Test

COVID-19 DNA-Based Risk and Immunity Test

immunity logo.png

 Genomepatri™ Immunity - a personalized genomic assessment of your body's immune response and risk for infections (including coronavirus).

Genomepatri™ Immunity is a DNA-based immunity assessment, for better prevention and health. You will get 15 reports which help you discover genetic strengths and vulnerabilities which affect your body's immune response and risk for disease, including coronavirus infection. This includes extensive analysis of your genetic predisposition to viral invasions (such as COVID-19), nutrient requirements which boost your immunity, reaction to antiviral drugs and potential health risks that need to be managed.



Genetic factors play an important role in immunity, including antiviral 
activity and recovery. Genomepatri Immunity(TM) is a DNA-based assessment of certain factors which affect your overall immunity and risk for infection, such as COVID-19.

Mapmygenome has developed a test that analyzes your risk of infection, seriousness of infection and whether drugs being tested right now work for you. We also report on nutrients that boost your immunity to fight off infection.


Screen Shot 2020-05-13 at 1.31.39 PM.png

For Infection Susceptibiltiy:

Carriers of certain genetic variants are more likely to suffer from coronavirus infection.
Genetic variations can affect processes like viral replication, cytokine production, regulation & immune response.

Screen Shot 2020-05-13 at 1.31.45 PM.png

For Knowing COVID-19 Severity :

Carriers of certain genetic variants are more likely to suffer from severe COVID- 19 outcomes, due to a phenomenon know as 'Cytokine storm', a hyper- responsive immune system which blocks the airways.
Since immune flare-ups are a hallmark feature of autoimmune disorders (eg., lupus) - genetic risk for these conditions could be linked with likelihood for poor COVID-19 outcomes, due to immune dysregulation.

Those affected with , or at risk for cardiovascular complications, are also potentially at risk for more severe forms of COVID-19 infection.

Screen Shot 2020-05-13 at 1.32.03 PM.png

For Optimal Therapy :

Carriers of certain genetic variants are more likely to suffer from severe adverse effects of drugs. The USFDA recommends genetic testing prior to drugs administration, for these drugs. Genetic variations can affect processes like drug metabolism & toxicity.

Screen Shot 2020-05-13 at 1.31.56 PM.png

For Nutritional Needs :

Genetic variations can affect processes like vitamin & mineral activation, conversion & their overall levels in the body.
Carriers of certain genetic variants are more likely to develop nutrient deficiencies and thereby, weaker immunity.


Genomepatri Immunity is done in partnership with Mapmygenome, one of the largest genomics testing companies in the world.


Our DNA Test is a simple non-invasive saliva sample home test which can be done anytime, anywhere.

Once we have mapped your DNA and completed our analysis, a thorough report is sent to you with the details.

We then schedule a video conference session (45 mins) with one of our excellent genetic counselors to speak to you about your results and offer insight and guidance, after which a post-counseling report is provided to you.

*Genomepatri Immunity is not a diagnostic report. It is genomics-based risk assessment - genetic predisposition only.
This report cannot be used as confirmation of positive/negative results for COVID-19. Having a risk for any of the conditions in the report does not mean you will, or that you will not, be infected with COVID-19.

For any information on Covid-19 Diagnostic Testing/Treatment resources in Egypt, Visit:


In Partnership With 

bottom of page